ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 134459 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 134459; 2) Community: the network communities that were significantly associated with the response to NSC 134459; 3) Molecule: the relationships between components within communities and NSC 134459; 4) MDR: the compounds that were significantly associated with the NSC 134459.

NSC Compound Enrichment Correlation
NSC 46401 .alpha.-Sarcin 0.0133299224082803 0.08863276
NSC 59220 [[5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3, 4-dihydroxyoxolan-2-yl]methoxy-ydroxyphosphoryl] [3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate, disodium salt 0.0133299224082803 0.37499663
NSC 606498 Camptothecin Derivative 0.0133299224082803 0.52045305
NSC 609699 Topotecan hydrochloride 0.0133299224082803 0.54683864
NSC 610458 Camptothecin Derivative 0.0133299224082803 0.63380327
NSC 621322 Null 0.0133299224082803 0.075897627
NSC 627168 2-[(3-N',N'-Dimethylamino)propyl]-9-methoxy-5-nitro-[6H]- pyrazolo[3,4,5-kl]acridine, free base 0.0133299224082803 0.24204142
NSC 631075 Null 0.0133299224082803 0.1580487
NSC 638441 Null 0.0133299224082803 0.49567601
NSC 639174 Camptothecin Derivative 0.0133299224082803 0.56731725
Total:128  Current:55    [First] [Prev] [Next] [Last]